XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:          
Net income (loss) $ (3,598) $ (48,577) $ 46,984 $ (1,040)  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization     170,757 151,945  
Non-cash operating lease costs     5,603 8,392  
Share-based compensation     33,676 30,633  
Provision for credit losses on accounts receivable     2,493 2,289  
Provision for credit losses 17,566 0 17,566 0  
Deferred income taxes, net     1,167 (14,575)  
Loss on sale of businesses 0 0 0 3,780  
Goodwill impairment   85,273 17,579 85,273  
Changes in fair value of contingent consideration     (2,834) 0  
Income from equity method investments, net     (11,783) (8,095)  
Gain (loss) on investments, net (678) 0 (5,018) 7,654  
Other     2,403 2,390  
Decrease (increase) in:          
Accounts receivable     187,760 46,576  
Prepaid expenses and other current assets     (10,325) (8,152)  
Other assets     14,658 (2,794)  
Increase (decrease) in:          
Accounts payable     (240,398) (66,313)  
Deferred revenue     (4,708) 9,269  
Accrued liabilities and other current liabilities     (9,594) (15,150)  
Net cash provided by operating activities     215,986 232,082  
Cash flows from investing activities:          
Purchases of property and equipment     (85,888) (79,476)  
Acquisitions, net of cash received     (67,086) (211,526)  
Distribution from equity method investment     10,756 0  
Proceeds from sale of equity method investment     860 0  
Proceeds from sale of equity investments     25,250 19,455  
Proceeds from sale of businesses, net of cash divested     0 7,860  
Other     (263) (884)  
Net cash used in investing activities     (116,371) (264,571)  
Cash flows from financing activities:          
Payment of debt     0 (134,989)  
Repurchase of common stock     (113,221) (183,981)  
Issuance of common stock under employee stock purchase plan     3,751 4,525  
Deferred payments for acquisitions     (213) (7,442)  
Other     (1,783) (1,209)  
Net cash used in financing activities     (111,466) (323,096)  
Effect of exchange rate changes on cash and cash equivalents     9,339 4,095  
Net change in cash and cash equivalents     (2,512) (351,490)  
Cash and cash equivalents at beginning of period     505,880 737,612 $ 737,612
Cash and cash equivalents at end of period $ 503,368 $ 386,122 $ 503,368 $ 386,122 $ 505,880